55 related articles for article (PubMed ID: 7854087)
1. [Expression of p53 in gastric carcinoma. Prognostic value].
Sundblad A; Pellicer EM; Mehta P; Ahn C; Battifora H
Medicina (B Aires); 1994; 54(3):216-20. PubMed ID: 7854087
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
5. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
6. [p53 gene deletion and abnormal expression in gastric carcinoma].
Yang D; Li T; Xu W
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):175-8. PubMed ID: 7656819
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
9. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53.
Iannettoni MD; Lee SS; Bonnell MR; Sell TL; Whyte RI; Orringer MB; Beer DG
Ann Thorac Surg; 1996 Nov; 62(5):1460-5; discussion 1465-6. PubMed ID: 8893584
[TBL] [Abstract][Full Text] [Related]
10. p53 expression as a prognostic indicator of 5-year survival in endometrial cancer.
Geisler JP; Geisler HE; Wiemann MC; Zhou Z; Miller GA; Crabtree W
Gynecol Oncol; 1999 Sep; 74(3):468-71. PubMed ID: 10479512
[TBL] [Abstract][Full Text] [Related]
11. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
13. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
14. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
15. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
16. Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers.
Shiao YH; Palli D; Caporaso NE; Alvord WG; Amorosi A; Nesi G; Saieva C; Masala G; Fraumeni JF; Rice JM
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):631-3. PubMed ID: 10868700
[TBL] [Abstract][Full Text] [Related]
17. p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.
Hughes JH; Cohen MB; Robinson RA
Mod Pathol; 1995 Jun; 8(5):462-6. PubMed ID: 7675761
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
19. [Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis].
Zhang S; Ye S; Lin H
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):418-21. PubMed ID: 8697991
[TBL] [Abstract][Full Text] [Related]
20. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
